The global HIV/AIDS epidemic still currently affects approximately 38 million individuals globally. The protease enzyme of the human immunodeficiency virus is a major drug target …
Abstract HIV-1 protease (HIV PR) is one of the most promising targets for anti-HIV drug discovery. Extensive anti-HIV drug discovery research was focused on HIV-1 subtype B …
D Sherry, R Worth, ZS Ismail, Y Sayed - Journal of Molecular Graphics and …, 2021 - Elsevier
The HIV-1 protease is an important drug target in antiretroviral therapy due to the crucial role it plays in viral maturation. A greater understanding of the dynamics of the protease as a …
It is well known that understanding the catalytic mechanism of HIV-1 PR is the rationale on which its inhibitors were developed; therefore, a better understanding of the mechanism of …
S Eche, A Kumar, N Sonela… - Journal of Biomolecular …, 2024 - Taylor & Francis
Highly mutated HIV-1 protease (PR) compromises the efficacy of lopinavir (LPV) and darunavir (DRV) used to formulate salvage regimens in HIV/AIDS management. Here, we …
SI Maphumulo, AK Halder, T Govender… - Chemical biology & …, 2018 - Wiley Online Library
HIV‐1 protease (HIV PR) is considered as one of the most attractive targets for the treatment of HIV and the impact of flap dynamics of HIV PR on the binding affinities of protease …
D Sherry, R Worth, Y Sayed - Protein Reviews: Volume 22, 2021 - Springer
HIV protease plays a critical role in the life cycle of the virus through the generation of mature and infectious virions. Detailed knowledge of the structure of the enzyme and its …
Human immunodeficiency virus (HIV), a precursor for AIDS is still one of the most devastating pandemics in history. In 2021 alone there were 650 000 deaths associated with …
HIV-1 protease plays a crucial role in the maturation of the virus by cleaving gag and gag- pol polyproteins. Understanding the structural and functional consequences of mutations in …